Skip to content

Genetic Risk Factors for Severe Asthma

Genetic Risk Factors for Severe Asthma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00090740
Enrollment
600
Registered
2004-09-06
Start date
2004-09-30
Completion date
2005-01-31
Last updated
2013-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

The purpose of this study is to determine whether a specific genetic factor influences the severity of asthma symptoms.

Detailed description

Asthma is one of the most common chronic diseases in the United States. It is well known that asthma susceptibility is inherited; however, it is unknown if asthma severity is heritable. Studies suggest that levels of interleukin-16 (IL-16) may influence asthma severity. This study will examine the role of differences in the control region of the IL-16 gene in a racially diverse group of asthmatics and nonasthmatics and will determine if the IL-16 gene control region is related to asthma severity. Participants in this study will undergo lung function and blood tests; they will also complete a questionnaire about their respiratory health. Asthmatic participants will complete a severity-of-asthma questionnaire.

Interventions

None listed

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
Lead SponsorNIH

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 44 Years
Healthy volunteers
No

Inclusion criteria

for Asthmatic Participants: * Diagnosis of asthma Inclusion Criteria for Non-asthmatic Participants: * No diagnosis of asthma

Design outcomes

Primary

MeasureTime frame
Examination of the relationship between the IL-16 promoter genotype and the presence of the asthma phenotypeThroughout study
Examination of the relationship between the IL-16 promoter genotype and asthma severityThroughout study
Examination of the serum IL-16 concentration and the serum IL-16:IL-9, IL-16:IL-13, and IL-16: TNF-alpha ratios as possible intermediate phenotypes lining the IL-16 promoter genotype to asthma severityThroughout study

Secondary

MeasureTime frame
Storage of DNA from all 600 participants for future study into the determinants of asthma severityThroughout study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026